114 related articles for article (PubMed ID: 38309729)
1. Course and predictors of excellent response to therapy in patients with differentiated thyroid cancer at long-term follow-up.
Samargandy SA; Qorban GN; Aljadani AK; Almufarji SS; Azab AM; Merdad MA; Al-Hajeili MR; Samargandy SJ
Saudi Med J; 2024 Feb; 45(2):139-146. PubMed ID: 38309729
[TBL] [Abstract][Full Text] [Related]
2. Incomplete response to therapy in intermediate- and high-risk thyroid cancer.
Alzahrani AS; Mukhtar N
Endocrine; 2022 Dec; 78(3):531-542. PubMed ID: 36074242
[TBL] [Abstract][Full Text] [Related]
3. The American Thyroid Association risk stratification and long-term outcomes of differentiated thyroid cancer: a 20-year follow-up of patients in Saudi Arabia.
Jammah AA; AlSadhan IM; Alyusuf EY; Alajmi M; Alhamoudi A; Al-Sofiani ME
Front Endocrinol (Lausanne); 2023; 14():1256232. PubMed ID: 38047113
[TBL] [Abstract][Full Text] [Related]
4. Natural Course of the American Thyroid Association Response to Therapy Statuses (Dynamic Risk Stratification) in Differentiated Thyroid Cancer.
Mukhtar N; Aljamei H; Aljomaiah A; Moria Y; Alzahrani AS
Eur Thyroid J; 2021 Jun; 10(3):198-207. PubMed ID: 34178705
[TBL] [Abstract][Full Text] [Related]
5. Age, American Thyroid Association Risk Group, and Response to Therapy Are Prognostic Factors in Children With Differentiated Thyroid Cancer.
Redlich A; Luster M; Lorenz K; Lessel L; Rohrer TR; Schmid KW; Frühwald MC; Vorwerk P; Kuhlen M
J Clin Endocrinol Metab; 2022 Jan; 107(1):e165-e177. PubMed ID: 34415989
[TBL] [Abstract][Full Text] [Related]
6. Dynamic Risk Stratification for Predicting Long-term Outcomes in Pediatric Differentiated Thyroid Cancers.
Majeed AK; Satapathy S; Ballal S; Bal C
J Clin Endocrinol Metab; 2023 May; 108(6):e208-e215. PubMed ID: 36577747
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of low-dose and high-dose postoperative radioiodine therapy in patients with intermediate-risk differentiated thyroid cancer.
Jeong JH; Kong EJ; Jeong SY; Lee SW; Cho IH; Ah Chun K; Lee J; Ahn BC
Nucl Med Commun; 2017 Mar; 38(3):228-233. PubMed ID: 27984538
[TBL] [Abstract][Full Text] [Related]
8. Dynamic Risk Stratification for Predicting Recurrence in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine Remnant Ablation Therapy.
Park S; Kim WG; Song E; Oh HS; Kim M; Kwon H; Jeon MJ; Kim TY; Shong YK; Kim WB
Thyroid; 2017 Apr; 27(4):524-530. PubMed ID: 27869547
[TBL] [Abstract][Full Text] [Related]
9. Dynamic Risk Stratification in the Follow-Up of Children and Adolescents with Differentiated Thyroid Cancer.
Zanella AB; Scheffel RS; Nava CF; Golbert L; Laurini de Souza Meyer E; Punales M; Gonçalves I; Dora JM; Maia AL
Thyroid; 2018 Oct; 28(10):1285-1292. PubMed ID: 30129889
[TBL] [Abstract][Full Text] [Related]
10. Differentiated Thyroid Cancers in Young Adults Versus Children: Clinical Characteristics and 10-year Follow-up Outcomes.
Satapathy S; Majeed AK; Ballal S; Bal C
J Clin Endocrinol Metab; 2023 Nov; 108(12):e1670-e1677. PubMed ID: 37285485
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and long-term outcomes for parapharyngeal metastases of well-differentiated thyroid cancer during
Deng XZ; Shi YF; Shen CT; Song HJ; Wang J; Fan YB; Luo QY; Qiu ZL
Clin Endocrinol (Oxf); 2023 Jul; 99(1):92-102. PubMed ID: 37029081
[TBL] [Abstract][Full Text] [Related]
12. Response to Therapy Status Is an Excellent Predictor of Pregnancy-Associated Structural Disease Progression in Patients Previously Treated for Differentiated Thyroid Cancer.
Rakhlin L; Fish S; Tuttle RM
Thyroid; 2017 Mar; 27(3):396-401. PubMed ID: 27835925
[TBL] [Abstract][Full Text] [Related]
13. Dynamic Risk Stratification in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine.
Momesso DP; Vaisman F; Yang SP; Bulzico DA; Corbo R; Vaisman M; Tuttle RM
J Clin Endocrinol Metab; 2016 Jul; 101(7):2692-700. PubMed ID: 27023446
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the 2015 American Thyroid Association Risk Stratification System in High-Risk Papillary and Follicular Thyroid Cancer Patients.
van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
Thyroid; 2019 Aug; 29(8):1073-1079. PubMed ID: 31140385
[No Abstract] [Full Text] [Related]
15. [Significance of Dynamic Risk Assessment in the Follow-up of Non-distant Metastatic Differentiated Thyroid Cancer Patients with Intermediate and High Risk].
Liu JR; Liu YQ; Li H; Liang J; Lin YS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Apr; 42(2):222-227. PubMed ID: 32385029
[No Abstract] [Full Text] [Related]
16. LONG-TERM OUTCOMES AND PROGNOSTIC FACTORS IN PATIENTS WITH DIFFERENTIATED THYROID CANCER AND DISTANT METASTASES.
Hirsch D; Levy S; Tsvetov G; Gorshtein A; Slutzky-Shraga I; Akirov A; Robenshtok E; Shimon I; Benbassat CA
Endocr Pract; 2017 Oct; 23(10):1193-1200. PubMed ID: 28704099
[TBL] [Abstract][Full Text] [Related]
17. Tumor burden of persistent disease in patients with differentiated thyroid cancer: correlation with postoperative risk-stratification and impact on outcome.
Ciappuccini R; Heutte N; Lasne-Cardon A; Saguet-Rysanek V; Leroy C; Le Hénaff V; Vaur D; Babin E; Bardet S
BMC Cancer; 2020 Aug; 20(1):765. PubMed ID: 32799836
[TBL] [Abstract][Full Text] [Related]
18. Outcomes after radioiodine ablation in patients with thyroid cancer: Long-term follow-up of a Chinese randomized clinicaltrial.
Dong P; Qu Y; Yang L; Xiao L; Huang R; Li L
Clin Endocrinol (Oxf); 2021 Nov; 95(5):782-789. PubMed ID: 34368999
[TBL] [Abstract][Full Text] [Related]
19. Modified dynamic risk stratification for predicting recurrence using the response to initial therapy in patients with differentiated thyroid carcinoma.
Jeon MJ; Kim WG; Park WR; Han JM; Kim TY; Song DE; Chung KW; Ryu JS; Hong SJ; Shong YK; Kim WB
Eur J Endocrinol; 2014 Jan; 170(1):23-30. PubMed ID: 24088549
[TBL] [Abstract][Full Text] [Related]
20. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.
Handkiewicz-Junak D; Wloch J; Roskosz J; Krajewska J; Kropinska A; Pomorski L; Kukulska A; Prokurat A; Wygoda Z; Jarzab B
J Nucl Med; 2007 Jun; 48(6):879-88. PubMed ID: 17536106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
